#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	528	70	ANT_2____Ia	750	210	98.59	ANT_2____Ia.l15.c4.ctg.1	521	6.6	0	.	p	.	0	F31_V32insG	INS	91	91	T	138	138	T	6	T	6	.	ANT(2'')-Ia;Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	280	CRP	633	633	99.37	CRP.l6.c30.ctg.1	1119	13.3	0	.	p	.	0	K29T	NONSYN	85	87	AAG	268	270	ACG	11;11;12	A;C;G	11;11;12	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	280	CRP	633	633	99.37	CRP.l6.c30.ctg.1	1119	13.3	0	.	p	.	0	T209S	NONSYN	625	627	ACT	808	810	TCT	8;8;8	T;C;T	8;7;8	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	T879G	SNP	879	879	T	17	17	G	1	G	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	G880A	SNP	880	880	G	18	18	A	1	A	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	A888G	SNP	888	888	A	26	26	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	C897G	SNP	897	897	C	35	35	G	6	G	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	T898C	SNP	898	898	T	36	36	C	7	C	7	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	G906T	SNP	906	906	G	44	44	T	13	T	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	G908A	SNP	908	908	G	46	46	A	13	A	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	A918T	SNP	918	918	A	56	56	T	12	T	12	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	A943G	SNP	943	943	A	81	81	G	21	G	21	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	134	Chlamydophila_psittaci_16S	1507	133	90.98	Chlamydophila_psittaci_16S.l15.c4.ctg.2	133	11.2	0	.	n	.	0	G991T	SNP	991	991	G	129	129	T	14	T	14	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	842	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1691	25.7	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1427	1429	AGC	18;18;17	A,G;G;C	12,6;18;17	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	842	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1691	25.7	0	HET	.	.	.	C954T	.	954	954	C	1201	1201	C	38	C,T	23,15	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	842	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1691	25.7	0	HET	.	.	.	C216T	.	216	216	C	463	463	C	29	C,T	16,13	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	406	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1493	13.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1353	1355	AAA	7;6;6	A;A;A	7;6;6	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	432	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l6.c17.ctg.1	1650	13.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1192	1194	GAA	14;14;14	G;A;A	14;14;14	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	126	H_NS	414	414	99.03	H_NS.l6.c30.ctg.1	770	8.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	316	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1499	11.3	0	.	p	.	0	H2R	NONSYN	4	6	CAT	239	241	CGT	8;8;8	C;G;T	8;8;8	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	316	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1499	11.3	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1082	1084	GGC	10;10;10	G;G;C	10;10;10	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	494	PmrC	1644	1644	99.15	PmrC.l6.c17.ctg.1	2010	13.1	0	.	p	.	0	R8S	NONSYN	22	24	AGA	228	230	AGC	8;7;7	A;G;C	8;7;7	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	494	PmrC	1644	1644	99.15	PmrC.l6.c17.ctg.1	2010	13.1	0	.	p	.	0	I142L	NONSYN	424	426	ATA	630	632	CTA	16;16;16	C;T;A	16;16;16	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	494	PmrC	1644	1644	99.15	PmrC.l6.c17.ctg.1	2010	13.1	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1149	1151	CAA	16;17;16	C;A;A	16;17;16	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	494	PmrC	1644	1644	99.15	PmrC.l6.c17.ctg.1	2010	13.1	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1248	1250	GGT	15;15;15	G;G;T	15;15;15	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	494	PmrC	1644	1644	99.15	PmrC.l6.c17.ctg.1	2010	13.1	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1818	1820	GTT	9;9;7	G;T;T	9;9;7	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	268	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1384	9.9	0	.	p	.	0	A125E	NONSYN	373	375	GCA	514	516	GAA	11;10;9	G;A;A	11;10;9	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	268	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1384	9.9	0	.	p	.	0	M185T	NONSYN	553	555	ATG	694	696	ACC	7;6;6	A;C;C	7;6;6	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	268	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1384	9.9	0	.	p	.	0	S225T	NONSYN	673	675	TCC	814	816	ACT	3;3;3	A;C;T	3;3;3	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	268	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1384	9.9	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1204	1206	ATC	8;8;8	A;T;C	8;8;8	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	517	298	PmrF	969	552	99.09	PmrF.l6.c17.ctg.1	663	9.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	517	298	PmrF	969	260	98.85	PmrF.l6.c17.ctg.2	260	13.8	0	.	p	.	0	N145S	NONSYN	433	435	AAC	248	250	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	517	298	PmrF	969	230	100.0	PmrF.l6.c17.ctg.3	377	14.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	528	50	TEM_1+	858	205	98.54	TEM_1+.l6.c30.ctg.1	228	4.4	0	.	p	.	0	L73R	NONSYN	217	219	CTG	186	188	CGT	1;1;1	C;G;T	0;0;0	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
aadA.3002601.NC_010410.3621491_3622283.725	aadA.3002601.NC_010410.3621491_3622283.725	1	0	27	282	aad-	792	792	100.0	aad-.l15.c30.ctg.1	1121	12.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	F31_V32insG	INS	91	91	T	138	138	T	6	T	6	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	D71N	NONSYN	211	213	GAC	261	263	AAC	10;10;10	A;A;C	10;10;10	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	V75E	NONSYN	223	225	GTA	273	275	GAA	6;6;6	G;A;A	6;6;6	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	T78I	NONSYN	232	234	ACC	282	284	ATC	5;5;5	A;T;C	5;5;5	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	I79A	NONSYN	235	237	ATC	285	287	GCC	5;4;4	G;C;C	5;4;4	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	I81V	NONSYN	241	243	ATT	291	293	GTA	4;4;4	G;T;A	4;4;4	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	N83T	NONSYN	247	249	AAC	297	299	ACT	2;2;2	A;C;T	2;2;2	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	L89V	NONSYN	265	267	CTA	315	317	GTT	3;3;3	G;T;T	3;3;3	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	S90G	NONSYN	268	270	AGC	318	320	GGC	3;3;3	G;G;C	3;3;3	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	S98P	NONSYN	292	294	TCA	342	344	CCG	4;4;4	C;C;G	4;4;4	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	Y117H	NONSYN	349	351	TAC	399	401	CAC	8;8;7	C;A;C	8;8;7	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	A127T	NONSYN	379	381	GCC	429	431	ACC	4;4;4	A;C;C	4;4;4	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	K129R	NONSYN	385	387	AAG	435	437	AGG	4;4;3	A;G;G	4;4;3	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	L139I	NONSYN	415	417	CTC	465	467	ATC	2;2;2	A;T;C	2;2;2	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	M143L	NONSYN	427	429	ATG	477	479	TTG	3;3;3	T;T;G	3;3;3	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	A145T	NONSYN	433	435	GCT	483	485	ACT	3;4;4	A;C;T	3;4;4	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	F148S	NONSYN	442	444	TTC	492	494	TCC	6;6;6	T;C;C	6;6;6	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	T154I	NONSYN	460	462	ACG	510	512	ATT	5;5;5	A;T;T	5;5;5	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	I158V	NONSYN	472	474	ATA	522	524	GTA	5;5;5	G;T;A	5;5;5	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	521	91.79	aadA-.l15.c4.ctg.1	571	6.6	0	.	p	.	0	L162I	NONSYN	484	486	CTT	534	536	ATT	5;5;5	A;T;T	5;5;5	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
aadA.3002601.NC_017645.1.114243_115218.3587	aadA.3002601.NC_017645.1.114243_115218.3587	1	0	512	96	aadA-	975	109	98.17	aadA-.l15.c4.ctg.3	121	3.1	0	.	p	.	0	I270V	NONSYN	808	810	ATA	63	65	GTA	2;2;2	G;T;A	2;2;2	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	818	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3449	12.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	457	459	ATC	6;6;5	A;T;C	6;6;5	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	818	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3449	12.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2170	2172	AAG	4;4;4	A;A;G	4;4;4	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	336	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1353	12.9	0	.	p	.	0	A22V	NONSYN	64	66	GCC	129	131	GTC	8;8;8	G;T;C	8;8;8	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	336	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1353	12.9	0	.	p	.	0	S269C	NONSYN	805	807	AGC	870	872	TGC	17;17;17	T;G;C	17;17;17	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	976	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3188	16.1	0	.	p	.	0	S46trunc	TRUNC	136	136	T	162	162	T	6	T	6	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	976	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3188	16.1	0	.	p	.	0	G148D	NONSYN	442	444	GGC	468	470	GAC	20;21;19	G;A;C	20;21;19	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	976	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3188	16.1	0	.	p	.	0	F240L	NONSYN	718	720	TTT	744	746	TTA	7;7;7	T;T;A	7;7;7	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	976	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3188	16.1	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1821	1823	AAT	17;16;17	A;A;T	17;16;17	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	976	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3188	16.1	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1935	1937	AGT	20;19;19	A;G;T	20;19;19	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	976	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3188	16.1	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2334	2336	GTG	12;11;11	G;T;G	12;11;11	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	976	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3188	16.1	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2889	2891	AAG	9;9;10	A;A;G	9;9;10	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	228	acrR_2	648	648	99.54	acrR_2.l6.c4.ctg.1	1003	12.2	1	SNP	p	R45C	0	.	.	133	135	CGC	321	323	CGC	18;21;22	C;G;C	18;21;22	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	214	acrS	663	663	98.79	acrS.l15.c4.ctg.1	860	13.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	130	132	TTC	10;10;9	T;T;C	10;10;9	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	214	acrS	663	663	98.79	acrS.l15.c4.ctg.1	860	13.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	394	396	GGG	15;15;14	G;G;G	15;15;14	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	278	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1123	13.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	597	599	CTT	13;13;14	C;T;T	13;13;14	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	812	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3037	14.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2049	2051	GCA	8;10;11	G;C;A	8;10;11	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	812	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3037	14.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2310	2312	ACC	18;19;19	A;C;C	18;19;19	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	812	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3037	14.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2619	2621	GCC	9;9;9	G;C;C	9;9;9	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	484	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1790	13.6	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	16	18	TGC	1;1;3	T;G;C	1;1;3	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	484	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1790	13.6	0	.	p	.	0	I150V	NONSYN	448	450	ATT	199	201	GTT	4;4;4	G;T;T	4;4;4	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	484	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1790	13.6	0	.	p	.	0	R200H	NONSYN	598	600	CGC	349	351	CAC	5;5;5	C;A;C	5;5;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	484	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1790	13.6	0	.	p	.	0	T295M	NONSYN	883	885	ACG	634	636	ATG	13;13;15	A;T;G	12;12;14	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	484	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1790	13.6	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1630	1632	CGC	6;6;6	C;G;C	6;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	484	arnA_1	1983	229	97.38	arnA_1.l6.c17.ctg.2	280	3.3	0	.	p	.	0	G37A	NONSYN	109	111	GGT	160	162	GCT	3;4;4	G;C;T	3;4;4	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	190	bacA	822	822	98.54	bacA.l15.c4.ctg.1	863	10.7	0	.	p	.	0	S221T	NONSYN	661	663	AGC	680	682	ACC	9;9;8	A;C;C	9;8;8	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	190	bacA	822	822	98.54	bacA.l15.c4.ctg.1	863	10.7	0	.	p	.	0	P225S	NONSYN	673	675	CCG	692	694	TCG	5;5;5	T;C;G	5;5;5	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	19	220	baeR	723	683	97.66	baeR.l15.c4.ctg.1	902	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	531	330	baeS	1404	1312	98.86	baeS.l15.c30.ctg.1	1381	11.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1195	1197	AAA	11;11;11	A;A;A	11;11;11	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	531	330	baeS	1404	1312	98.86	baeS.l15.c30.ctg.1	1381	11.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1207	1209	GAG	8;8;8	G;A;G	8;8;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	531	330	baeS	1404	1312	98.86	baeS.l15.c30.ctg.1	1381	11.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1213	1215	CAC	7;6;6	C;A;C	7;5;5	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	531	330	baeS	1404	1312	98.86	baeS.l15.c30.ctg.1	1381	11.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1267	1269	GAG	6;7;7	G;A;G	6;7;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	446	cpxA	1374	1374	98.91	cpxA.l6.c4.ctg.1	1811	13.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	294	cpxR	699	699	99.43	cpxR.l6.c4.ctg.1	1070	14.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	238	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1314	9.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfhr3b.manually_added_AY162283_AAN85115.1_5616_6095	dfhr3b.manually_added_AY162283_AAN85115.1_5616_6095	1	0	27	184	dfhr3b	480	480	100.0	dfhr3b.l15.c4.ctg.1	821	12.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: AY162283.2 Citrobacter freundii transposon class I integron In38 IntI1 integron integrase (intI1) gene, partial cds, aminoglycoside (6') N-acetyltransferase AAC(6')-II (aacA4), beta-lactamase OXA-4 (bla(OXA-4)), quaternary ammonium compound resistance protein (qacEdelta1), dihydropteroate synthase (sul1), Orf513 (orf513), dihydrofolate reductase type IIIb (dfrA3b), and Orf105 (orf105) genes, complete cds, qacEdelta1 pseudogene, complete sequence, and dihydropteroate synthase (sul1) gene, partial cds
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	531	356	emrA	1173	1154	98.27	emrA.l15.c30.ctg.1	1256	14.0	0	.	p	.	0	W42C	NONSYN	124	126	TGG	105	107	TGT	9;9;9	T;G;T	9;9;9	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	531	356	emrA	1173	1154	98.27	emrA.l15.c30.ctg.1	1256	14.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	636	638	GTC	12;12;11	G;T;C	12;12;11	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	504	emrB	1539	1539	99.81	emrB.l15.c4.ctg.1	1855	14.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	531	364	emrD	1191	1176	98.55	emrD.l6.c4.ctg.2	1435	13.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	884	886	AGC	6;6;7	A;G;C	6;6;7	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	26	emrE_1	333	93	96.77	emrE_1.l15.c4.ctg.2	93	7.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	262	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1270	10.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	719	721	AGG	7;7;7	A;G;G	7;7;7	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	262	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1270	10.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1109	1111	GAC	4;4;4	G;A;C	4;4;4	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	240	emrR	531	531	100.0	emrR.l15.c30.ctg.1	969	13.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	514	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1910	14.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	202	evgA	615	615	99.19	evgA.l6.c30.ctg.1	996	10.9	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	384	386	CTG	12;13;13	C;T;G	12;13;13	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	197	199	AAA	11;10;10	A;A;A	11;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	932	934	CAT	9;9;9	C;A;T	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	986	988	CAT	14;14;14	C;A;T	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1004	1006	AGA	12;12;12	A;G;A	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1019	1021	AAT	11;11;12	A;A;T	11;11;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1166	1168	TCC	4;4;4	T;C;C	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1331	1333	ATT	9;9;10	A;T;T	9;9;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1352	1354	GAT	8;8;9	G;A;T	8;8;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1466	1468	GTT	14;14;14	G;T;T	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1751	1753	CAC	8;8;8	C;A;C	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	2490	97.87	evgS.l6.c4.ctg.1	2678	13.3	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	2489	2491	AAC	11;11;10	A;A;C	11;11;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	169	171	ATA	4;4;4	A;T;A	4;4;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	181	183	GTA	4;4;4	G;T;A	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	334	336	ACG	14;14;15	A;C;G	14;14;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	397	399	GAA	9;9;9	G;A;A	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	436	438	GCT	15;15;15	G;C;T	15;15;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	454	456	GAT	15;15;14	G;A;T	15;15;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	541	543	TCA	13;13;12	T;C;A	13;13;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	670	672	CAG	12;12;12	C;A;G	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	808	810	GTT	14;14;14	G;T;T	14;14;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	N303D	NONSYN	907	909	AAT	964	966	GAT	5;5;5	G;A;T	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	950	evgS	3594	1087	96.96	evgS.l6.c4.ctg.2	1144	12.7	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1132	1134	AAT	3;3;2	A;A;T	3;3;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	234	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1222	10.2	1	SNP	p	P64L	0	.	.	190	192	CCA	363	365	CCA	11;12;12	C;C;A	11;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	234	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1222	10.2	1	SNP	p	P64S	0	.	.	190	192	CCA	363	365	CCA	11;12;12	C;C;A	11;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	234	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1222	10.2	1	SNP	p	P64R	0	.	.	190	192	CCA	363	365	CCA	11;12;12	C;C;A	11;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	234	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1222	10.2	1	SNP	p	P64A	0	.	.	190	192	CCA	363	365	CCA	11;12;12	C;C;A	11;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	234	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1222	10.2	1	SNP	p	P64H	0	.	.	190	192	CCA	363	365	CCA	11;12;12	C;C;A	11;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	246	gadE	528	528	100.0	gadE.l15.c30.ctg.1	891	14.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	62	gadW	729	140	95.71	gadW.l15.c30.ctg.2	146	5.2	0	.	p	.	0	K110N	NONSYN	328	330	AAA	22	24	AAT	4;4;4	A;A;T	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	513	192	gadX	825	395	98.23	gadX.l15.c4.ctg.1	398	12.1	0	.	p	.	0	F53L	NONSYN	157	159	TTC	148	150	TTA	13;13;12	T;T;A	12;12;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	513	192	gadX	825	395	98.23	gadX.l15.c4.ctg.1	398	12.1	0	.	p	.	0	V79I	NONSYN	235	237	GTT	226	228	ATT	8;8;8	A;T;T	8;8;8	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	513	192	gadX	825	407	98.28	gadX.l15.c4.ctg.2	494	8.7	0	.	p	.	0	R246G	NONSYN	736	738	AGA	318	320	GGA	9;9;10	G;G;A	9;9;10	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	513	192	gadX	825	407	98.28	gadX.l15.c4.ctg.2	494	8.7	0	.	p	.	0	S248P	NONSYN	742	744	TCG	324	326	CCG	9;9;9	C;C;G	9;8;9	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	762	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2996	13.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2222	2224	GAA	12;13;14	G;A;A	12;13;13	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	762	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2996	13.6	1	SNP	p	S83I	0	.	.	247	249	TCG	437	439	TCG	14;14;13	T;C;G	14;14;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	762	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2996	13.6	1	SNP	p	S83W	0	.	.	247	249	TCG	437	439	TCG	14;14;13	T;C;G	14;14;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	762	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2996	13.6	1	SNP	p	S83L	0	.	.	247	249	TCG	437	439	TCG	14;14;13	T;C;G	14;14;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	762	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2996	13.6	1	SNP	p	D87G	0	.	.	259	261	GAC	449	451	GAC	11;11;11	G;A;C	10;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	762	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2996	13.6	1	SNP	p	D87V	0	.	.	259	261	GAC	449	451	GAC	11;11;11	G;A;C	10;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	762	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2996	13.6	1	SNP	p	D87H	0	.	.	259	261	GAC	449	451	GAC	11;11;11	G;A;C	10;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	762	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2996	13.6	1	SNP	p	D87N	0	.	.	259	261	GAC	449	451	GAC	11;11;11	G;A;C	10;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	762	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2996	13.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	449	451	GAC	11;11;11	G;A;C	10;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	684	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2772	13.1	1	SNP	p	R136S	0	.	.	406	408	CGC	579	581	CGC	13;11;12	C;G;C	13;11;11	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	684	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2772	13.1	1	SNP	p	R136G	0	.	.	406	408	CGC	579	581	CGC	13;11;12	C;G;C	13;11;11	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	684	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2772	13.1	1	SNP	p	R136L	0	.	.	406	408	CGC	579	581	CGC	13;11;12	C;G;C	13;11;11	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	684	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2772	13.1	1	SNP	p	R136I	0	.	.	406	408	CGC	579	581	CGC	13;11;12	C;G;C	13;11;11	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	684	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2772	13.1	1	SNP	p	R136C	0	.	.	406	408	CGC	579	581	CGC	13;11;12	C;G;C	13;11;11	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	684	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2772	13.1	1	SNP	p	R136H	0	.	.	406	408	CGC	579	581	CGC	13;11;12	C;G;C	13;11;11	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	684	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2772	13.1	1	SNP	p	R136E	0	.	.	406	408	CGC	579	581	CGC	13;11;12	C;G;C	13;11;11	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	178	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	899	10.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	312	314	CCG	12;12;12	C;C;G	12;12;12	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	178	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	899	10.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	465	467	GCC	13;13;13	G;C;C	13;13;13	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	350	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1335	14.0	0	.	p	.	0	P9S	NONSYN	25	27	CCA	190	192	TCA	9;10;10	T;C;A	9;10;10	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	124	marA	384	384	99.74	marA.l6.c4.ctg.1	707	9.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	358	360	AGC	3;3;2	A;G;C	3;3;2	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	460	462	CAT	3;3;3	C;A;T	2;2;3	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	V45E	0	.	.	133	135	GTG	184	186	GTG	7;7;7	G;T;G	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	I49S	0	.	.	145	147	ATC	196	198	ATC	4;4;4	A;T;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	A70T	0	.	.	208	210	GCA	259	261	GCA	7;7;8	G;C;A	7;7;8	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	R73C	0	.	.	217	219	CGT	268	270	CGT	8;8;8	C;G;T	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	R73S	0	.	.	217	219	CGT	268	270	CGT	8;8;8	C;G;T	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	R77L	0	.	.	229	231	CGC	280	282	CGC	8;7;7	C;G;C	8;7;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	R77C	0	.	.	229	231	CGC	280	282	CGC	8;7;7	C;G;C	8;7;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	L78M	0	.	.	232	234	CTG	283	285	CTG	7;7;7	C;T;G	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	R94H	0	.	.	280	282	CGC	331	333	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	R94S	0	.	.	280	282	CGC	331	333	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	433	97.69	marR.l6.c30.ctg.1	484	5.5	1	SNP	p	V96E	0	.	.	286	288	GTA	337	339	GTA	5;5;5	G;T;A	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	203	98.52	mdfA.l15.c4.ctg.1	332	10.2	0	.	p	.	0	L379Q	NONSYN	1135	1137	CTG	105	107	CAG	11;11;10	C;A;G	11;11;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	203	98.52	mdfA.l15.c4.ctg.1	332	10.2	0	.	p	.	0	L391W	NONSYN	1171	1173	TTG	141	143	TGG	6;6;5	T;G;G	6;6;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	740	97.7	mdfA.l15.c4.ctg.2	737	9.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	56	58	CAG	15;15;15	C;A;G	14;14;15	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	740	97.7	mdfA.l15.c4.ctg.2	737	9.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	95	97	GCC	7;7;7	G;C;C	7;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	740	97.7	mdfA.l15.c4.ctg.2	737	9.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	200	202	GCG	13;13;13	G;C;G	12;13;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	740	97.7	mdfA.l15.c4.ctg.2	737	9.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	404	406	GTT	7;7;7	G;T;T	5;6;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	740	97.7	mdfA.l15.c4.ctg.2	737	9.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	566	566	C	4	C	4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	281	94.31	mdfA.l15.c4.ctg.3	282	5.0	0	.	p	.	0	S7F	NONSYN	19	21	TCC	4	6	TTC	1;1;1	T;T;C	1;1;1	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	281	94.31	mdfA.l15.c4.ctg.3	282	5.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	91	93	ATC	6;6;6	A;T;C	6;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	281	94.31	mdfA.l15.c4.ctg.3	282	5.0	0	.	p	.	0	E42A	NONSYN	124	126	GAA	109	111	GCC	2;2;2	G;C;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	281	94.31	mdfA.l15.c4.ctg.3	282	5.0	0	.	p	.	0	N43V	NONSYN	127	129	AAT	112	114	GTG	2;2;2	G;T;G	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	281	94.31	mdfA.l15.c4.ctg.3	282	5.0	0	.	p	.	0	E52D	NONSYN	154	156	GAG	139	141	GAT	4;4;4	G;A;T	4;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	281	94.31	mdfA.l15.c4.ctg.3	282	5.0	0	.	p	.	0	N59T	NONSYN	175	177	AAC	160	162	ACC	4;4;5	A;C;C	4;4;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	236	mdfA	1233	281	94.31	mdfA.l15.c4.ctg.3	282	5.0	0	.	p	.	0	I68L	NONSYN	202	204	ATA	187	189	TTA	2;2;2	T;T;A	2;2;2	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	272	mdtA	1248	959	97.91	mdtA.l6.c4.ctg.1	1100	11.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	6	8	ATG	7;8;8	A;T;G	7;8;8	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	272	mdtA	1248	959	97.91	mdtA.l6.c4.ctg.1	1100	11.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	99	101	ACC	10;10;10	A;C;C	9;10;10	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	272	mdtA	1248	152	98.03	mdtA.l6.c4.ctg.2	152	7.3	0	.	p	.	0	V62I	NONSYN	184	186	GTT	82	84	ATT	3;3;3	A;T;T	2;3;2	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	272	mdtA	1248	152	98.03	mdtA.l6.c4.ctg.2	152	7.3	0	.	p	.	0	T83I	NONSYN	247	249	ACC	145	147	ATC	9;9;9	A;T;C	9;9;9	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	930	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3489	14.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1944	1946	ACC	16;15;16	A;C;C	16;15;16	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	930	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3489	14.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2337	2339	CAA	7;7;7	C;A;A	7;7;7	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	930	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3489	14.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2505	2507	ATT	10;10;10	A;T;T	10;10;10	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	930	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3489	14.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2589	2591	GTT	11;11;11	G;T;T	11;11;11	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	930	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3489	14.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2697	2699	GAG	6;6;6	G;A;G	6;6;6	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	930	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3489	14.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2925	2927	ATG	11;11;11	A;T;G	11;11;11	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	930	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3489	14.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3060	3062	GAT	11;15;16	G;A;T	11;15;16	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	900	mdtC	3078	2918	98.73	mdtC.l6.c30.ctg.1	2981	15.1	0	.	p	.	0	I46M	NONSYN	136	138	ATC	193	195	ATG	8;8;8	A;T;G	8;8;8	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	900	mdtC	3078	2918	98.73	mdtC.l6.c30.ctg.1	2981	15.1	0	.	p	.	0	V208I	NONSYN	622	624	GTC	679	681	ATC	10;11;11	A;T;C	10;11;11	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	900	mdtC	3078	2918	98.73	mdtC.l6.c30.ctg.1	2981	15.1	0	.	p	.	0	Y740S	NONSYN	2218	2220	TAC	2275	2277	TCC	18;16;16	T;C,A;C	17;1,9;16	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	900	mdtC	3078	2918	98.73	mdtC.l6.c30.ctg.1	2981	15.1	0	.	p	.	0	V969M	NONSYN	2905	2907	GTA	2962	2964	ATG	4;4;4	A,G;T;G	3,1;4;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	346	mdtD	1416	596	98.83	mdtD.l15.c4.ctg.1	751	9.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	161	163	GAA	7;7;7	G;A;A	7;7;7	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	346	mdtD	1416	819	98.17	mdtD.l15.c4.ctg.2	841	11.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	82	84	GCG	11;11;12	G;C;G	11;11;12	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	346	mdtD	1416	819	98.17	mdtD.l15.c4.ctg.2	841	11.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	424	426	ATC	3;3;4	A;T;C	3;3;4	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	346	mdtD	1416	819	98.17	mdtD.l15.c4.ctg.2	841	11.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	727	729	TTT	12;12;12	T;T;T	12;12;12	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	440	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1313	17.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	896	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3437	13.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1056	1058	ACC	12;12;13	A;C,A;C	12;10,1;13	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	896	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3437	13.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2298	2300	GAC	19;19;19	G;A;C,A	19;19;18,1	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	366	mdtG	1227	1047	99.43	mdtG.l6.c30.ctg.1	1393	11.5	0	.	p	.	0	V200I	NONSYN	598	600	GTC	580	582	ATC	12;12;13	A;T;C	12;12;13	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	366	mdtG	1227	181	99.45	mdtG.l6.c30.ctg.2	341	7.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	173	175	GGA	5;5;4	G;G;A	5;5;4	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	296	mdtH	1209	1203	98.0	mdtH.l15.c30.ctg.1	1309	11.4	0	.	p	.	0	G134C	NONSYN	400	402	GGT	394	396	TGT	9;10;10	T;G;T	9;10;10	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	296	mdtH	1209	1203	98.0	mdtH.l15.c30.ctg.1	1309	11.4	0	.	p	.	0	S324L	NONSYN	970	972	TCG	964	966	TTG	15;15;15	T;T;G	15;15;15	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	296	mdtH	1209	1203	98.0	mdtH.l15.c30.ctg.1	1309	11.4	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1174	1176	ACG	6;6;6	A;C;G	6;6;6	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	350	mdtL	1176	1176	98.21	mdtL.l15.c4.ctg.1	1559	12.1	0	.	p	.	0	A185S	NONSYN	553	555	GCC	754	756	TCC	15;16;15	T;C;C	15;15;14	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	260	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1497	9.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	557	559	ATT	8;7;7	A;T;T	8;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	564	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2131	13.8	0	.	p	.	0	V11M	NONSYN	31	33	GTG	67	69	ATG	4;4;4	A;T;G	4;4;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	564	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2131	13.8	0	.	p	.	0	T33I	NONSYN	97	99	ACC	133	135	ATC	9;9;10	A;T;C	9;9;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	564	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2131	13.8	0	.	p	.	0	C116R	NONSYN	346	348	TGC	382	384	CGC	12;13;12	C;G;C	12;13;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	564	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2131	13.8	0	.	p	.	0	N238S	NONSYN	712	714	AAC	748	750	AGC	21;21;21	A;G;C	21;21;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	564	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2131	13.8	0	.	p	.	0	M305V	NONSYN	913	915	ATG	949	951	GTG	12;13;13	G;T;G	12;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	564	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2131	13.8	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1012	1014	AAC	9;9;9	A;A;C	9;8;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	564	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2131	13.8	0	.	p	.	0	P330fs	FSHIFT	988	988	C	1024	1024	C	8	C	8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	245	245	T	19	T	19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	S129A	NONSYN	385	387	TCA	428	430	GCG	11;10;10	G;C;G	11;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	A187T	NONSYN	559	561	GCC	602	604	ACC	4;5;5	A;C;C	4;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	H211R	NONSYN	631	633	CAC	674	676	CGC	16;15;15	C;G;C	16;14;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	V250A	NONSYN	748	750	GTT	791	793	GCT	9;9;10	G;C;T	9;9;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	R278K	NONSYN	832	834	AGA	875	877	AAA	8;7;7	A;A;A	8;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	893	895	CGA	10;11;12	C;G;A	10;11;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1058	1060	GCC	9;9;9	G;C;C	9;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1070	1072	GAT	12;12;13	G;A;T	12;12;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	358	mdtP	1467	1452	97.87	mdtP.l15.c4.ctg.1	1495	12.0	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1487	1489	GCT	6;5;5	G;C;T	6;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	531	838	mfd	3447	3444	99.16	mfd.l15.c30.ctg.1	3613	12.3	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1306	1308	AAG	7;7;7	A;A;G	7;7;7	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	531	838	mfd	3447	3444	99.16	mfd.l15.c30.ctg.1	3613	12.3	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2383	2385	CTG	8;8;8	C;T;G	8;8;8	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	82	mgrB	144	143	100.0	mgrB.l15.c4.ctg.2	160	13.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	532	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1942	14.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	968	970	AAC	12;13;13	A;A;C	12;13;13	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	532	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1942	14.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1514	1516	ATA	22;21;21	A;T;A	22;21;21	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	392	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1316	14.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1128	1130	GAT	12;12;12	G;A;T	12;12;12	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	392	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1316	14.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1131	1133	CTG	12;13;13	C;T;G	12;13;13	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	194	nfsA	723	296	98.99	nfsA.l6.c30.ctg.1	426	6.9	0	.	p	.	0	R27C	NONSYN	79	81	CGT	209	211	TGT	9;10;9	T;G;T	9;10;9	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	194	nfsA	723	296	98.99	nfsA.l6.c30.ctg.1	426	6.9	1	SNP	p	R15C	0	.	.	43	45	CGC	173	175	CGC	11;10;9	C;G;C	11;10;9	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	194	nfsA	723	296	98.99	nfsA.l6.c30.ctg.1	426	6.9	1	SNP	p	S33R	0	.	.	97	99	AGC	227	229	AGC	6;6;6	A;G;C	6;6;6	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	194	nfsA	723	419	99.05	nfsA.l6.c30.ctg.2	834	7.7	0	.	p	.	0	I117T	NONSYN	349	351	ATC	227	229	ACC	12;12;13	A;C;C	12;12;13	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	194	nfsA	723	419	99.05	nfsA.l6.c30.ctg.2	834	7.7	0	.	p	.	0	G187D	NONSYN	559	561	GGC	437	439	GAC	15;15;15	G;A;C	15;15;15	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	194	nfsA	723	419	99.05	nfsA.l6.c30.ctg.2	834	7.7	1	SNP	p	G131D	0	.	.	391	393	GGC	269	271	GGC	13;12;12	G;G;C	13;12;12	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	194	nfsA	723	419	99.05	nfsA.l6.c30.ctg.2	834	7.7	1	SNP	p	R203L	0	.	.	607	609	CGT	485	487	CGT	12;12;11	C;G;T	12;11;11	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	194	nfsA	723	419	99.05	nfsA.l6.c30.ctg.2	834	7.7	1	SNP	p	R203C	0	.	.	607	609	CGT	485	487	CGT	12;12;11	C;G;T	12;11;11	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	316	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1342	12.3	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1149	1151	GAG	11;10;10	G;A;G	11;10;10	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	316	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1342	12.3	1	SNP	p	G141D	0	.	.	421	423	GGT	636	638	GGT	18;19;20	G;G;T	18;19;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	316	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1342	12.3	1	SNP	p	G141E	0	.	.	421	423	GGT	636	638	GGT	18;19;20	G;G;T	18;19;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	316	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1342	12.3	1	SNP	p	R154D	0	.	.	460	462	CGT	675	677	CGT	18;18;18	C;G;T	18;18;18	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	316	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1342	12.3	1	SNP	p	R154A	0	.	.	460	462	CGT	675	677	CGT	18;18;18	C;G;T	18;18;18	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	776	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2456	16.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1812	1814	TCG	16;16;16	T;C;G	16;16;16	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	776	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2456	16.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2427	2429	AAC	9;9;9	A;A;C	9;9;9	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	776	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2456	16.5	1	SNP	p	A85T	0	.	.	253	255	GCG	441	443	GCG	17;18;18	G;C;G	17;17;18	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	776	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2456	16.5	1	SNP	p	D111H	0	.	.	331	333	GAT	519	521	GAT	20;20;20	G;A;T	20;20;20	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	776	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2456	16.5	1	SNP	p	S129P	0	.	.	385	387	TCC	573	575	TCC	15;15;14	T;C;C	15;15;14	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	570	parE_1	1893	1746	97.48	parE_1.l15.c4.ctg.1	1950	14.2	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1279	1281	GAT	26;26;28	G;A;T	26;26;28	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	570	parE_1	1893	149	98.66	parE_1.l15.c4.ctg.3	166	12.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	430	patA	1380	1380	99.86	patA.l15.c30.ctg.1	1835	12.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1292	1294	GAT	9;8;8	G;A;T	9;8;8	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	V146F	0	.	.	436	438	GTT	612	614	GTT	15;15;15	G;T;T	15;15;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1713	1715	CAG	23;23;23	C;A;G	23;23;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1713	1715	CAG	23;23;23	C;A;G	23;23;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1752	1754	CAC	17;17;17	C;A;C	17;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1761	1763	CGT	15;15;14	C;G;T	15;15;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1761	1763	CGT	15;15;14	C;G;T	15;15;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1767	1769	TCC	13;13;13	T;C;C	13;13;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1773	1775	CTC	13;13;13	C;T;C	13;13;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1863	1865	ACC	22;22;22	A;C;C	22;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1866	1868	CCT	22;23;23	C;C;T	22;23;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1286	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4254	15.9	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2235	2237	CGT	10;10;10	C;G;T	10;10;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	.	n	.	0	A226G	SNP	226	226	A	351	351	G	142	G	142	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	.	n	.	0	C719T	SNP	719	719	C	844	844	T	100	T,C	50,50	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	1	SNP	n	A794G	0	.	.	794	794	A	919	919	A	100	A	99	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	1	SNP	n	A794T	0	.	.	794	794	A	919	919	A	100	A	99	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	1	SNP	n	G926C	0	.	.	926	926	G	1051	1051	G	101	G	101	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	1	SNP	n	G926T	0	.	.	926	926	G	1051	1051	G	101	G	101	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	1	SNP	n	G926A	0	.	.	926	926	G	1051	1051	G	101	G	101	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	HET	.	.	.	C680T	.	680	680	C	805	805	C	130	C,T	112,18	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	HET	.	.	.	A79G	.	79	79	A	204	204	A	106	A,G	81,24	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	HET	.	.	.	T273A	.	273	273	T	398	398	T	101	T,A	73,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	HET	.	.	.	C183T	.	183	183	C	308	308	C	133	C,T	96,37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	HET	.	.	.	A250T	.	250	250	A	375	375	A	117	A,T	87,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	HET	.	.	.	T90C	.	90	90	T	215	215	T	108	T,C	82,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	HET	.	.	.	G474A	.	474	474	G	599	599	G	105	G,A	79,24	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	HET	.	.	.	A253T	.	253	253	A	378	378	A	115	A,T	86,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1126	107.5	0	HET	.	.	.	C194T	.	194	194	C	319	319	C	132	C,T	109,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.2	517	110.3	1	SNP	n	A1519G	0	.	.	1519	1519	A	480	480	A	84	A	84	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.2	517	110.3	1	SNP	n	A1519T	0	.	.	1519	1519	A	480	480	A	84	A	84	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	641	3604	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.2	517	110.3	1	SNP	n	A1519C	0	.	.	1519	1519	A	480	480	A	84	A	84	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	192	soxR	465	465	100.0	soxR.l15.c4.ctg.1	754	13.3	1	SNP	p	R20H	0	.	.	58	60	CGC	195	197	CGC	16;17;17	C;G;C	16;17;17	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	192	soxR	465	465	100.0	soxR.l15.c4.ctg.1	754	13.3	1	SNP	p	G121D	0	.	.	361	363	GGT	498	500	GGT	12;13;11	G;G;T	12;13;11	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	142	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	676	11.1	1	SNP	p	A12S	0	.	.	34	36	GCA	224	226	GCA	19;19;19	G;C;A	19;19;19	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
sul1.3000410.JF969163.1053_1893.340	sul1.3000410.JF969163.1053_1893.340	1	0	27	456	sul1	840	840	100.0	sul1.l15.c30.ctg.1	1166	19.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Sul1 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria. It is linked to other resistance genes of class 1 integrons.;sul1
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	16	14	tet-	1206	117	100.0	tet-.l15.c4.ctg.1	117	1.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.;tetA
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	496	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1856	14.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
